On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayDec 22, 2022 11:08 am

NetworkNewsBreaks – Aegis Capital Corp. Acted as Sole Bookrunner on BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) $8M Underwritten Public Offering

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Aegis Capital Corp., which is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions, acted as sole bookrunner on an $8 million underwritten public offering for BiondVax Pharmaceuticals. BiondVax expects to use the net proceeds from the offering, together with its existing cash and cash equivalents, for the advancement of its nanosized antibody (“NanoAb”) development program and general corporate purposes. To view the full…

Continue Reading

WednesdayDec 21, 2022 4:08 pm

NetworkNewsBreaks – CubCrafters Inc. Eyes Great Potential Growth with Summit Brand on Heels of Acquisition

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has announced its acquisition of Summit Aircraft Skis, including the company’s design and manufacturing assets, unique patents and related intellectual property, from the Sandpoint, Idaho-based Summit Aircraft Corporation. Favored by Carbon Cub owners, Summit Aircraft Skis are also preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft. The unique ski design enables pilots to quickly and easily configure their aircraft to fly to many remote and primitive areas otherwise inaccessible in winter when runways are not maintained. “We are very…

Continue Reading

WednesdayDec 21, 2022 4:00 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR and Emergency Communication Services for Five New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts for its Autonomous Security Robot (“ASR”) and Blue Light Emergency Communication services across multiple U.S. states. The contracts and deployment locations include a property management group in Chicago, a police department in North Carolina, another tribal casino client in Oklahoma, an airport in New Jersey, as well as a construction company in Texas. The announcement reads, “Knightscope’s expanded product line is helping its clients protect the places people live, work, study and visit in many new ways. In addition to…

Continue Reading

WednesdayDec 21, 2022 2:43 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower dose levels than other CBD formulations to achieve effective levels within the blood stream, as supported by this pharmaceutical-industry peer comparison,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “This is extremely important to patients…

Continue Reading

WednesdayDec 21, 2022 1:59 pm

NetworkNewsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes filing of an environmental permit followed by construction permit application for phase 1 400,000 cubic meters (“CBM”) capacity. The latter will be a phased submission, with each phase designed in accordance with commercial storage requirements…

Continue Reading

WednesdayDec 21, 2022 1:33 pm

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Implements Digital Coupon Strategy to Drive Shareholder Engagement

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced it is rewarding all shareholders of record a digital coupon (“NFT”) redeemable for a gift package of company products valued at over $179 to drive shareholder engagement and additional revenue potential. According to the announcement, shareholders of record will be able to redeem the coupon to try the product first-hand or trade it with other fans globally on Upstream to bring new potential customers into the community. “By incorporating Upstream’s Web3 digital coupons into our strategy, we aim to provide our shareholders with first-hand experience…

Continue Reading

WednesdayDec 21, 2022 1:20 pm

NetworkNewsBreaks – SideChannel Inc. (SDCH) Releases Fiscal Year 2022 Report, Featured in CBC News Interview

SideChannel Inc. (OTCQB: SDCH), a provider of cybersecurity services and technology for emerging and middle market companies, reported on its fiscal year ended Sept. 30, 2022. Highlights of the report include revenue for the company reaching $4.8 million, a 71% increase over 2021, with vCISO revenue totaling $3.1 million, an increase of 93% over 2021. SideChannel’s recurring vCISO revenue reportedly increased by 562% and recurring software and services revenue increased by 367%. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” said SideChannel CEO Brian Haugli in the press release. “Our investments…

Continue Reading

WednesdayDec 21, 2022 10:49 am

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Recaps 2022 as a Tremendous Year of Technology and Milestones

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative power conversion technologies and control system solutions for next-generation electrical systems, today issued a recap of the significant progress achieved by the company during the year. “2022 has been a tremendous year for Hillcrest, as the company met or exceeded every milestone we set out to achieve. We are proud of the incredible progress made thus far,” said Hillcrest CEO Don Currie. “We entered the year with a proof of concept for our core technology, the Hillcrest ZVS inverter technology, and progressed through design, commissioning and finally completion of…

Continue Reading

TuesdayDec 20, 2022 3:26 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

Continue Reading

TuesdayDec 20, 2022 2:23 pm

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced the closing of its underwritten public offering with gross proceeds to the company to be $8,000,000. The offering consists of 1,600,000 units and pre-funded units, with each unit consisting of one American Depositary Share (“ADS”) and two warrants, each to purchase one ADS. Each pre-funded unit consists of one pre-funded warrant to purchase one ADS and two warrants each to purchase one ADS. BiondVax expects to use the net proceeds, together with its existing…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217